Clinical Trial Update: Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating sunitinib malate for advanced eye disease in von Hippel-Lindau syndrome was terminated; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Hippel-lindau Syndrome

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Von Hippel-Lindau Syndrome | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2011-12-19